Author:
Trevidic Patrick,Connolly Simon A.,Biwer Bernard,Ellers-Lenz Barbara,Harrington Laura S.,Kestemont Philippe,Noah Ernst M.,Sattler Gerhard,Weissenberger Petra,Kerscher Martina
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Dermatology,General Medicine,Surgery
Reference16 articles.
1. Multicenter, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown lines;Carruthers;Dermatol Surg,2013
2. A randomized, placebo-controlled, double-blind phase III trial investigating the efficacy and safety of incobotulinumtoxinA in the treatment of glabellar frown lines using a stringent composite endpoint;Hanke;Dermatol Surg,2013
3. Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study;Prager;Dermatol Surg,2010
4. Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines;Sattler;Dermatol Surg,2010
5. A phase III study of incobotulinumtoxinA in the treatment of glabellar frown lines;Imhof;J Clin Aesthet Dermatol,2011
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献